Article

Optimisation of anti-platelet therapy in acute coronary syndromes

2019-01-01

Abstract excerpt

Acute coronary syndromes (ACS) are a major cause of morbidity and mortality worldwide. Platelets are central to the underlying pathology of ACS, and anti-platelet drugs, such as aspirin, clopidogrel and ticagrelor, form a cornerstone of its treatment. However, response to anti-platelet drugs is not uniform, with a substantial proportion of patients being nonresponsive to their effects, leading to an increase in ri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0eb109d8-7fe5-5946-a263-bff0ebf7c6ee
DOI: 10.17638/03060576

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimisation of anti-platelet therapy in acute coronary syndromesDOI 10.17638/03060576Read

Investigating the mechanisms of hyporesponse to antiplatelet approaches.Semantic proximity Read

Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.Semantic proximity Read

Options to overcome clopidogrel response variability.Semantic proximity Read

Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.Semantic proximity Read

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).Semantic proximity Read

Clinical, genetic and confounding factors determine the dynamics of the in vitro response/non response to clopidogrelSemantic proximity Read

Review of aspirin and clopidogrel resistance in peripheral arterial disease.Semantic proximity Read

A brief review on the mechanisms of aspirin resistance.Semantic proximity Read

P2Y12 receptor inhibitor resistance and coronary artery disease: a bench to bedside primer for cardiovascular specialists.Semantic proximity Read

Platelet function and response to low-dose aspirin in pregnancySemantic proximity Read

Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.Semantic proximity Read